183 related articles for article (PubMed ID: 6318200)
1. Predominant involvement of mu-rather than delta- or kappa-opiate receptors in LH secretion.
Pfeiffer DG; Pfeiffer A; Shimohigashi Y; Merriam GR; Loriaux DL
Peptides; 1983; 4(5):647-9. PubMed ID: 6318200
[TBL] [Abstract][Full Text] [Related]
2. Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion.
Pfeiffer DG; Pfeiffer A; Almeida OF; Herz A
J Endocrinol; 1987 Sep; 114(3):469-76. PubMed ID: 2822829
[TBL] [Abstract][Full Text] [Related]
3. Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes.
Walsh JP; Clarke IJ
Endocrinology; 1996 Sep; 137(9):3640-8. PubMed ID: 8756528
[TBL] [Abstract][Full Text] [Related]
4. Effects of specific activation of mu-, delta- and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat.
Leadem CA; Yagenova SV
Neuroendocrinology; 1987 Feb; 45(2):109-17. PubMed ID: 3033534
[TBL] [Abstract][Full Text] [Related]
5. Medial preoptic-anterior hypothalamic area involvement in the suppression of pulsatile LH release by a mu-opioid agonist in the ovariectomized rat.
Mallory DS; Gallo RV
Brain Res Bull; 1990 Aug; 25(2):251-7. PubMed ID: 2171721
[TBL] [Abstract][Full Text] [Related]
6. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
Cicero TJ; Meyer ER; Miller BT; Bell RD
J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
[TBL] [Abstract][Full Text] [Related]
7. Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion.
Panerai AE; Petraglia F; Sacerdote P; Genazzani AR
Endocrinology; 1985 Sep; 117(3):1096-9. PubMed ID: 2990867
[TBL] [Abstract][Full Text] [Related]
8. Relative effectiveness of naloxone and MR2266 in potentiating oestrogen-stimulated luteinizing hormone surges in ovariectomized female rats.
Dyer RG; Mansfield S; Dean AD
Neurosci Lett; 1984 Aug; 49(1-2):111-5. PubMed ID: 6093001
[TBL] [Abstract][Full Text] [Related]
9. Differential cardiovascular effects mediated by mu and kappa opiate receptors in hindbrain nuclei.
Hassen AH; Feuerstein G; Faden AI
Peptides; 1983; 4(5):621-5. PubMed ID: 6318199
[TBL] [Abstract][Full Text] [Related]
10. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
[TBL] [Abstract][Full Text] [Related]
11. The antinociceptive role of mu- and delta-opiate receptors and their interactions in the spinal dorsal horn of cats.
Omote K; Kitahata LM; Collins JG; Nakatani K; Nakagawa I
Anesth Analg; 1990 Jul; 71(1):23-8. PubMed ID: 1973027
[TBL] [Abstract][Full Text] [Related]
12. Gonadal steroid modulation of brain opioid systems.
Limonta P; Maggi R; Dondi D; Martini L; Piva F
J Steroid Biochem; 1987; 27(4-6):691-8. PubMed ID: 2826902
[TBL] [Abstract][Full Text] [Related]
13. Rotational behavior mediated by dopaminergic and nondopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists.
Matsumoto RR; Brinsfield KH; Patrick RL; Walker JM
J Pharmacol Exp Ther; 1988 Jul; 246(1):196-203. PubMed ID: 2839661
[TBL] [Abstract][Full Text] [Related]
14. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
Rivest S; Plotsky PM; Rivier C
Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
[TBL] [Abstract][Full Text] [Related]
15. The effects of mu-, delta- and kappa-opioid receptor activation on luteinizing and follicle-stimulating hormone secretion from porcine pituitary cells.
Wylot B; Tworus K; Okrasa S
J Physiol Pharmacol; 2013 Aug; 64(4):505-11. PubMed ID: 24101398
[TBL] [Abstract][Full Text] [Related]
16. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
Iyengar S; Kim HS; Wood PL
J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
[TBL] [Abstract][Full Text] [Related]
18. Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women.
Bondanelli M; Ambrosio MR; Franceschetti P; Guerrini R; Valentini A; degli Uberti EC
Hum Reprod; 1998 May; 13(5):1159-62. PubMed ID: 9647539
[TBL] [Abstract][Full Text] [Related]
19. Effects of different opiates on hypothalamic monoamine turnover and on plasma LH levels in pro-oestrous rats.
Gopalan C; Gilmore DP; Brown CH
J Neurol Sci; 1989 Dec; 94(1-3):211-9. PubMed ID: 2559164
[TBL] [Abstract][Full Text] [Related]
20. The opioid receptor subtypes mu and kappa, but not delta, are involved in the control of the vasopressin and oxytocin release in the rat.
Van de Heijning BJ; Koekkoek-Van den Herik I; Van Wimersma Greidanus TB
Eur J Pharmacol; 1991 Dec; 209(3):199-206. PubMed ID: 1665795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
